Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications Journal Article


Authors: DeSancho, M. T.; Pastores, S. M.
Article Title: Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications
Keywords: major clinical study; disease course; mortality; drug efficacy; drug safety; treatment duration; note; outcome assessment; quality of life; incidence; deep vein thrombosis; lung embolism; thromboembolism; fondaparinux; randomized controlled trial (topic); thrombosis prevention; leg thrombophlebitis
Journal Title: Evidence-Based Medicine
Volume: 18
Issue: 1
ISSN: 1356-5524
Publisher: BMJ Publishing Group Ltd.  
Date Published: 2013-02-01
Start Page: 28
End Page: 29
Language: English
DOI: 10.1136/eb-2012-100755
PROVIDER: scopus
PUBMED: 22740355
DOI/URL:
Notes: --- - "Export Date: 1 March 2013" - "CODEN: EBMEF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Stephen Pastores
    249 Pastores